You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Wilms' Tumor 1 (WT1)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)

Active, not recruiting
  • Mesothelioma
  • +2 more
  • Galinpepimut-S
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Nov 23, 2022

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

Recruiting
  • Wilms Tumor
  • +6 more
  • Los Angeles, California
  • +10 more
Aug 2, 2023

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and

Completed
  • Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
    • Roma, Italy
      Servizio E Dh Di Ematologia
    Feb 23, 2023

    Colorectal Cancer, Gastric Cancer, Pancreatic Cancer Trial in Huntersville, Canton (CUE-102)

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Huntersville, North Carolina
    • +1 more
    Jul 5, 2022

    Acute Myeloid Leukemia Trial in Belgium (DC vaccine)

    Recruiting
    • Acute Myeloid Leukemia
    • DC vaccine
    • Antwerp, Belgium
    • +7 more
    Jan 15, 2021

    International PPB/DICER1 Registry

    Recruiting
    • Pleuropulmonary Blastoma
    • +14 more
      • Minneapolis, Minnesota
        Children's Minnesota
      Aug 16, 2022

      Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

      Completed
      • Multiple Myeloma
      • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
      • Standard of care
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 22, 2022

      Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

      Recruiting
      • Pediatric Solid Tumor
      • +15 more
      • second generation 4-1BBζ EGFR806-EGFRt
      • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
      • Seattle, Washington
        Seattle Children's Hospital
      May 2, 2022

      Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

      Terminated
      Has Results
      • Acute Myeloid Leukemia
      • +4 more
      • Aldesleukin
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 15, 2021

      Advanced Malignancies, Advanced Cancer Trial in United States (ASP7517, Pembrolizumab)

      Recruiting
      • Advanced Malignancies
      • Advanced Cancer
      • Atlanta, Georgia
      • +3 more
      Aug 2, 2022

      Familial Investigations of Childhood Cancer Predisposition

      Recruiting
      • Acute Leukemia
      • +45 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        May 11, 2022

        Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

        Terminated
        • Lymphoma
        • +15 more
        • Charlottesville, Virginia
          University of Virginia
        Feb 8, 2022

        Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

        Terminated
        Has Results
        • Advanced Pleural Malignant Mesothelioma
        • +10 more
        • Aldesleukin
        • +4 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Aug 16, 2021

        Colonic Tumors Trial in Wuhan (neoadjuvant chemo)

        Recruiting
        • Colonic Neoplasms
        • neoadjuvant chemotherapy
        • Wuhan, Hubei, China
          Tongji Hospital, Huazhong University of Science and Technology
        Jul 19, 2022

        Leukemia, Myelodysplastic Syndrome Trial in New York (WT1-sensitized T cells)

        Completed
        • Leukemia
        • Myelodysplastic Syndrome
        • WT1-sensitized T cells
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Mar 1, 2021

        Cardiac Functions in Type 1 Diabetes Mellitus

        Not yet recruiting
        • Diabetes Mellitus, Type 1
        • +2 more
        • transthoracic echocardiography
        • (no location specified)
        Nov 12, 2023

        Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

        Completed
        • Neuroblastoma
        • +5 more
        • Palo Alto, California
        • +5 more
        Feb 4, 2022

        1 asPotential Biomarker for Colorectal Cancer Diagnosis and

        Not yet recruiting
        • Colorectal Cancer
        • Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
        • (no location specified)
        Mar 20, 2023

        Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

        Not yet recruiting
        • Stage IIIA Hepatocellular Carcinoma
        • Radiotherapy combined with TKI and Anti-PD-1 Antibody
        • (no location specified)
        Sep 24, 2023

        NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

        Not yet recruiting
        • Non-small Cell Lung Cancer (NSCLC)
        • Tumor treating fields（EFE-P100）
        • Docetaxel injection
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Dec 21, 2022

        Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

        Not yet recruiting
        • Digestive System Neuroendocrine Tumor G1
        • +5 more
        • Tumor Debulking
        • +5 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Aug 23, 2023